Chris HardestyPartner at Pureland Venture

Chris L. Hardesty has lived and worked in more than 50 countries serving global health missions. 

He is currently a Strategic Advisor to APACMed for the shaping of digital health regulation and reimbursement policies, a Partner at Pureland Venture for early-stage technology development (such as in the space of decentralized diabetic retinopathy screening), as well as independent roles in the design of public-private financing frameworks like those used in lipohypertrophy educational programs.  Chris moreover works with many multinational as well as start-up companies to advise on their population health strategies.  He is a close friend of the French community, having supported the FCCS for many years and also originating his career at Laboratoire Boiron. 

Further details about Chris can be found here: https://www.linkedin.com/in/chardesty/